Takeda Malaysia Sdn. Bhd. is a Malaysia-based pharmaceutical company operating as the local subsidiary of Takeda Pharmaceutical Company Limited, a global biopharmaceutical group. The company is engaged in the marketing, distribution, and medical support of prescription pharmaceutical products across therapeutic areas including gastroenterology, oncology, rare diseases, neuroscience, and plasma-derived therapies. Its operations support hospitals, specialists, and healthcare institutions nationwide. Key assets include global research-driven product portfolios, regulatory and medical affairs capabilities, and established healthcare partnerships. Strategically, the company is positioned as an innovation-led pharmaceutical provider focused on patient-centric care, scientific excellence, and sustainable healthcare outcomes.
Headquarters
Unit Tb-L13-1, Level 13, Tower B, Plaza 33, No. 1, Jalan Kemajuan, Seksyen 13
Petaling Jaya; Selangor;
Postal Code: 46200
Contact Details: Purchase the Takeda Malaysia Sdn. Bhd. report to view the information.
Website: http://www.takeda.com/who-we-are/company-information/worldwide-offices/takeda-malaysia-sdn-bhd/
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service